OC-01 (varenicline) nasal spray 0.03 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OC-01 (varenicline) nasal spray 0.03 mg, covering 2022-08-24 to 2022-08-24. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray [Phase 4]